Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-2253

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-2253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine 150mg 70518 2253 01

OXcarbazepine is a prescription drug with 100 HD2 quantity. It is manufactured by Breckenridge in Boca Raton, FL 33487. The NDC number for the drug is 70518-2253-01 and the source NDC is 51991-0292-05. The drug should be kept away from children and stored at a temperature of 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F). The package insert should be consulted for directions for use. The drug has been repackaged by RemedyRepack Inc., Indiana, PA 15701.*

FDA Label Image

Oxcarbazepine 150mg 70518 2253 02

This is a prescription medication called OXcarbazepine. The label includes the quantity, prescription status, expiration date, and lot number. The manufacturer is listed as Breckenridge and the repackager as RemedyRepack Inc. The medication should be stored at 20-26°C (63-77°F), and excursions to 15-30°C (59-86°F) are permitted. A package insert should be consulted for directions on use. The label also includes NDC numbers and a warning to keep the medication out of the reach of children.*

FDA Label Image

Remedy_label (Remedy Label)

Oxcarbazepine is a medication that is available in a pack of 30 HD2. It is a prescription drug that should be kept away from kids. The package insert must be referred to for directions for use. It should be stored at a temperature of 20-26°C (63-77°F) and can have excursions within 15-30°C (59-86°F). The manufacturer of this drug is Breckenridge, Boca Raton, FL 33487, and it is repackaged by a RemedyRepack Inc., Indiana, PA 15701. The expiration date and LOT number are not available. The NDC number is 70518-2253-00, and the source NDC is 51991-0292-05.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This appears to be a graph depicting the exit rate with a log-rank test result and p-value of 0.0001. The graph has a line graph measuring the exit rate from day 2 to day 11 with a placebo label.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

The text is a chart showing the seizure rate in a treatment group on Oxcarbazepine compared to a placebo group. It includes a log-rank test with p-value of 0.046 and displays the days from the first dose to the first seizure.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This text describes the results of a log-rank test with a p-value of 0.0001. There is a graph with a time scale on the x-axis (in days) and a treatment group (HIGH and LOW) on the y-axis. The treatment group is related to an "exit rate" but it's unclear what that specifically refers to.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

The text describes a statistical analysis of two treatment groups based on their "Time to exit" measured in days. The "Exitrate" is mentioned with a value of 0. A "log-rank" test was performed, and the obtained p-value is 0.0001, which suggests significant differences between groups. The numbers 10 to 130 are likely to represent time intervals. The treatment groups are labeled as "HIGH" and "LOW."*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.